GB1511602A - Protein having thymus hormone-like activity - Google Patents

Protein having thymus hormone-like activity

Info

Publication number
GB1511602A
GB1511602A GB1100976A GB1100976A GB1511602A GB 1511602 A GB1511602 A GB 1511602A GB 1100976 A GB1100976 A GB 1100976A GB 1100976 A GB1100976 A GB 1100976A GB 1511602 A GB1511602 A GB 1511602A
Authority
GB
United Kingdom
Prior art keywords
prealbumin
daltons
subjecting
march
chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1100976A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/658,200 external-priority patent/US4046877A/en
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of GB1511602A publication Critical patent/GB1511602A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GB1100976A 1975-03-24 1976-03-18 Protein having thymus hormone-like activity Expired GB1511602A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56140975A 1975-03-24 1975-03-24
US59711675A 1975-07-18 1975-07-18
US05/658,200 US4046877A (en) 1975-07-18 1976-02-17 Method of increasing immunologic competence

Publications (1)

Publication Number Publication Date
GB1511602A true GB1511602A (en) 1978-05-24

Family

ID=27415851

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1100976A Expired GB1511602A (en) 1975-03-24 1976-03-18 Protein having thymus hormone-like activity

Country Status (11)

Country Link
JP (1) JPS51118822A (fr)
AU (1) AU509024B2 (fr)
CA (1) CA1056305A (fr)
DE (1) DE2612015A1 (fr)
ES (1) ES446334A1 (fr)
FR (1) FR2305191A1 (fr)
GB (1) GB1511602A (fr)
IE (1) IE43573B1 (fr)
NL (1) NL7603020A (fr)
NZ (1) NZ180367A (fr)
SE (1) SE7603556L (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149468B1 (fr) * 1984-01-12 1990-10-31 SYMBIOTEC Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie GmbH Substance biologiquement active à caractères hormonaux, procédé de préparation et utilisation d'histones dans des buts médicinaux

Also Published As

Publication number Publication date
NZ180367A (en) 1978-07-28
AU509024B2 (en) 1980-04-17
AU1230876A (en) 1977-09-29
FR2305191B1 (fr) 1978-11-17
IE43573L (en) 1976-09-24
ES446334A1 (es) 1977-12-16
FR2305191A1 (fr) 1976-10-22
JPS51118822A (en) 1976-10-19
SE7603556L (sv) 1976-10-22
CA1056305A (fr) 1979-06-12
DE2612015A1 (de) 1976-10-14
IE43573B1 (en) 1981-04-08
NL7603020A (nl) 1976-09-28

Similar Documents

Publication Publication Date Title
EP0384288A3 (fr) Dérivés de pipéridine, leur préparation et leur utilisation
HUT47130A (en) Process for producing 9alpha-hydroxysteroids, as well as 9(11)-dehydro derivatives and pharmaceutical compositions comprising these active ingredients
OA08505A (fr) Nouveaux steroides comportant un cycle spirannique en position 17, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
AU7474187A (en) Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation
CA2093806A1 (fr) Methode de traitement ou de prevention du diabete de type 1 par l'administration orale d'insuline
EP0184309A3 (fr) Peptides contenant des esters 11 à 23 du VIP
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
DE69033538D1 (de) Verfahren zur Herstellung der 1,2-Doppelbindung von 4-aza-Steroiden und kristallinen Proscor(R) und pharmazeutische Präparate davon
HUT43494A (en) Process for producing pharmaceutical composition containing interferone-alpha
IL73521A (en) Preparation of 1,3,5-tri-o-acyl-2-deoxy-2-fluoroarabinofuranoside intermediate compounds for the synthesis of nucleosides and the 1,3,5-triaroyl esters thereof
FR2314729A1 (fr) Solution injectable d'hemoglobine ne renfermant pas de stroma et procede de sa preparation
EP0225020A3 (fr) Peptides comprenant dans leur séquence des unités sélectionnées parmi les restes d'acides aminés 17 à 24 du VIP
EP0286441A3 (fr) Protéine cytotoxique
FI871087A (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
IT7950847A0 (it) Derivati amminici dotati di attivi ta' farmacologica e procedimento per la loro preparazione
GB1511602A (en) Protein having thymus hormone-like activity
FR2556721B1 (fr) Nouveaux derives de o-mercaptopropanamide d'o amino-acides, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2566779B2 (fr) Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
OA07558A (fr) Nouveaux dérivés dichlorés de la série du 16@- méthyl pregnane, leur préparation, leur application comme médicaments et les compositions les renfermant.
BE877658A (fr) Nouveaux derives acetyleniques de l'androst-4-ene, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FI890678A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
AT361124B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen zur topischen verabreichung an das auge
PT83984A (en) Process for the preparation of novel 16,17-acetalsubstituted pregnane 21-oic derivatives and of pharmaceutical compositions containing the same
BE878256A (fr) Nouveaux derives acetyleniques de l'androst-4-ene, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2561919B1 (fr) Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee